Deutsche Bank
ABOS icon

Deutsche Bank’s Acumen Pharmaceuticals ABOS Stock Holding History

Deutsche Bank’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
+46,132
New +$114K ﹤0.01% 3426
2025
Q2 		– Sell
-96,995
Closed -$107K – 3601
2025
Q1 		$107K Hold
96,995
– – ﹤0.01% 3170
2024
Q4 		$167K Buy
96,995
+79,940
+469% +$192K ﹤0.01% 3146
2024
Q3 		$42.3K Sell
17,055
-16,594
-49% -$45K ﹤0.01% 3393
2024
Q2 		$81.4K Buy
+33,649
New +$107K ﹤0.01% 3180
2022
Q2 		– Sell
-15,501
Closed -$61K – 4115
2022
Q1 		$61K Buy
15,501
+9,677
+166% +$52.6K ﹤0.01% 3768
2021
Q4 		$39K Buy
5,824
+306
+6% +$3.36K ﹤0.01% 4023
2021
Q3 		$82K Buy
+5,518
New +$91.8K ﹤0.01% 3966

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Deutsche Bank's ABOS Position: Q2 2026 in Review

Deutsche Bank opened a new position in Acumen Pharmaceuticals (ABOS) in Q2 2026: 46,132 shares worth $123K. The stake represents ﹤0.01% of the portfolio and ranks #3426 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in ABOS as recently as Q1 2025.

Deutsche Bank first reported a position in ABOS in Q3 2021 and has held it in 8 quarters since. The position peaked at $167K in Q4 2024. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Deutsche Bank held 46,132 shares of Acumen Pharmaceuticals worth $123K as of Q2 2026.
  • Acumen Pharmaceuticals was a new Deutsche Bank position in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3426 holding.
  • Deutsche Bank first reported a position in Acumen Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
  • Deutsche Bank's Acumen Pharmaceuticals position peaked at $167K in Q4 2024.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.